Epidarex Capital
Epidarex Capital

Epidarex Capital

DR36Ahrefs DR: 36/100. Below median. Measured by Ahrefs. Median 44.

Transatlantic venture capital firm funding transformative life science opportunities in emerging US and UK research hubs.

Website
2010VC28 portfolio$247.0M AUMBethesda, United States

About

Epidarex Capital is a transatlantic venture capital firm that identifies and funds transformative life science opportunities in emerging and under-ventured research hubs within the US and UK. The firm provides seed or Series A funds to spin out innovations from highly regarded medical research universities and institutions, aiming to build extraordinary companies that translate novel science into successful drugs and medical devices.

Key facts

At-a-glance profile data

Website
epidarex.com
Type
VC
Headquarters
Bethesda, United States
Funds raised
$247M
Portfolio companies
28
Stages
Pre-Seed
Seed
Series A
Sector focus
Life Sciences
Biotechnology
Pharmaceuticals
Medical Devices
Health Technology

Recent investments

Recent funding rounds Epidarex Capital took part in
DateCompanyRoundAmount
1 Aug 2026MironidSeries B$46M
Add first review

Frequently asked

What companies has Epidarex Capital invested in?

Epidarex Capital has invested in Mironid, Topas Therapeutics, Lunac Therapeutics, Lario Therapeutics, Harpoon Medical, Inc. and 23 more.

Founders (1)
KS
Kyparissia Sirinakis
Founding Partner

Find a founder email